gemcitabine has been researched along with gw 3965 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Addanki, S; Bollu, LR; Candelaria, NR; Dey, P; Fisher, WE; Gabbi, C; Gustafsson, JÅ; Hodges, SE; Issazadeh, MA; Ittmann, MM; Jonsson, PK; Karaboga, H; Lin, CY; Lin, JZ; Liu, K; McElhany, AL; Nguyen-Vu, T; Steffensen, KR; Su, F; Vedin, LL; Wu, W; Zheng, J | 1 |
2 other study(ies) available for gemcitabine and gw 3965
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Benzoates; Benzylamines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Female; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ligands; Liver X Receptors; Male; Microarray Analysis; Middle Aged; Neoplasm Proteins; Orphan Nuclear Receptors; Pancreatic Neoplasms; Signal Transduction | 2014 |